Is 6734.TWO overvalued or undervalued?

6734.TWO currently has a P/E ratio of -4.40. Relative to the sector average of 26.70, this suggests the stock may be undervalued. A higher P/E than peers means investors are paying more for each unit of earnings, often because they expect faster future growth. However, if that growth does not materialize, the stock can appear overvalued. A lower P/E may indicate weaker growth expectations or higher risk, but it can also signal a potential valuation discount.

How can I buy iXensor Co., Ltd. stock?

iXensor Co., Ltd. trades on TWO. Investors in Latin America can buy it through international and regional brokerage and investment platforms. You simply need a valid government ID or passport to get started.

Can I buy fractional shares of 6734.TWO?

Yes. Through fractional investing, you can invest exactly the amount you want, starting with as little as $1 or $5 USD (depending on what investment platform you use), and own a proportional piece of the company.

Does buying 6734.TWO protect my money against local inflation?

Many investors in Latin America buy international stocks like 6734.TWO to protect their purchasing power. Because 6734.TWO is priced in foreign currency, your investment is tied to a hard currency. If your local currency devalues against the foreign currency, usually USD or Euro, the underlying value of your stock portfolio remains protected from local inflation.

Do I need a foreign bank account or a Visa to buy 6734.TWO shares?

No. A common misconception is that you need a foreign bank account or a foreign visa to invest in international stocks. Today, modern investment platforms allow you to fund your account using local bank transfers or local payment methods right from your home country.

Is 6734.TWO a suitable investment for my portfolio?

There is no universal answer, since fit depends on your situation, not just the stock. Think about three things: how well 6734.TWO diversifies what you already own, whether you can stomach its price swings given your risk tolerance, and how long you plan to stay invested. As a rule, a single stock works best as one piece of a broader asset allocation and with a multi-year time horizon. This is general information, not personalized financial advice.

All stocks6734.TWO

iXensor Co., Ltd.

NT$5.33+NT$0.21+4.10%

TWO / TWD

Market cap

NT$221M

P/E

-4.4

EPS (TTM)

NT$-0.04

Dividend yield

0.00%

Beta

0.57

1Y return

-26.99%

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Compare, tap a companyup to 2 at once

Deposit US$200 and get US$50 for freeT&C apply. Your capital is at risk.Invest with

Financials

The numbers behind the company

Revenue vs net income

RevenueNet income

$894,4192021

$3M2022

$680,4382023

$592,6042024

$856,5632025

Financial health

Gross margin

Operating margin

ROE

ROA

Debt to equity3.20High
Current ratio1.17
Cash ratio0.63
Net margin-184.1%
Free cash flow—

Valuation

Is it expensive right now

P/E vs the market

scale 0–50

0153050

6734.TWO-4.4
Healthcare sector median26.7
S&P 50022.0

Trades about 116% below its sector, cheaper than its peers on earnings.

Ratios

PEG-0.15
Price to book25.20
EPS (TTM)NT$-0.04
Payout ratio0%
FCF yield-18.54%

Range & risk

NT$4.70NT$18.50

Trading in the lower third of its 52-week band

Beta0.57

Profile

What iXensor Co., Ltd. actually does

iXensor Co., Ltd. operates a cutting-edge technological platform that transforms standard smartphones into sophisticated in vitro diagnostic (IVD) instruments, advancing the field of connected healthcare. This innovation is powered by their proprietary PixoTest technology, which intelligently leverages a smartphone's integrated lighting and image sensing modules to accurately detect and interpret color-change reactions on immunoassay or colorimetric test strips. The company's diverse product portfolio addresses various health management needs: Chronic Diseases: Solutions like the PixoTest Blood Glucose Monitoring System and PixoTest POCT System assist in managing long-term conditions. Women's Health: The Eveline Smart Fertility System and Eveline Care Telehealth Platform provide tools for fertility tracking and remote care. Infectious Diseases: Offerings such as the PixoTest COVID-19 Rapid Antigen Test facilitate rapid detection and management. Additionally, iXensor provides supporting digital infrastructure, including the PixoHealth Pass Admin app and its corresponding web portal. Established in Taipei, Taiwan, in 2012, the company is a pioneer in mobile-driven diagnostic solutions.

CEO

Yanyu Chen

Employees

Headquarters

Taipei, TP

Founded

2019-06-28

Company website

If you had invested a decade ago

Loading the full price history…

Run your own numbers

Past performance is not a forecast.

ETFs

Own it inside an ETF instead

Vanguard S&P 500

Vanguard Total Stock Market

Vanguard Total World Stock

Invesco QQQ

SPDR S&P 500

iShares Russell 2000

Community sentiment

Bullish—

Distribution

Bearish0%
Neutral0%
Bullish0%

Track it without buyingTrack it

no account needed

Save 6734.TWO and get told when something moves.

Get updates

A clear, direct weekly summary.

Keep looking

Q&A

Questions people ask

6734.TWO has a beta of 0.57, which indicates how sensitive it has historically been to movements in its broader market. A beta below 1 indicates lower relative volatility than the market. Beta is based on historical data and does not predict future performance.

iXensor Co., Ltd.